You are here
Deciphering COVID-19 with digital innovations
To better combat COVID-19, experts from the Digital Health Center at the Berlin Institute of Health at Charité (BIH) are using genome sequencing to identify high-risk patients and develop better targeted treatment therapies. Such work generates and requires analysis of enormous pools of data. By leveraging Dell Technologies’ high performance computing (HPC) solutions, this has become possible. Learn more on Invested in Europe.